• Intellia Therapeutics (NASDAQ:NTLA) Given New $26.00 Price Target at Barclays

    Source: Buzz FX / 01 Mar 2025 18:06:12   America/New_York


    Intellia Therapeutics (NASDAQ:NTLA) Given New $26.00 Price Target at Barclays Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective lowered by Bar
    Read more...
Share on,